NewsStay Updated with the Latest News from 3billion.
3billion announces pathogenicity predictor ‘3Cnet’
3billion looks to 2022 IPO, expansion into drug discovery
Rare disease screening firm 3Billion closes $13M Series C financing
3billion aims for the global market by IPO
3billion Named “Next Unicorn” at ASEAN-Korea Scale-up Contest
3billion CEO: “We diagnose 7,000 rare diseases at once using AI”